BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22565824)

  • 21. Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes.
    Denning MF; Dlugosz AA; Cheng C; Dempsey PJ; Coffey RJ; Threadgill DW; Magnuson T; Yuspa SH
    Exp Dermatol; 2000 Jun; 9(3):192-9. PubMed ID: 10839717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAM17 transactivates EGFR signaling during embryonic eyelid closure.
    Hassemer EL; Endres B; Toonen JA; Ronchetti A; Dubielzig R; Sidjanin DJ
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):132-40. PubMed ID: 23211830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
    Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
    Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.
    Morgado-Pascual JL; Rayego-Mateos S; Valdivielso JM; Ortiz A; Egido J; Ruiz-Ortega M
    Biomed Res Int; 2015; 2015():783538. PubMed ID: 26064952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes.
    Hall KC; Hill D; Otero M; Plumb DA; Froemel D; Dragomir CL; Maretzky T; Boskey A; Crawford HC; Selleri L; Goldring MB; Blobel CP
    Mol Cell Biol; 2013 Aug; 33(16):3077-90. PubMed ID: 23732913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
    Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
    Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.
    Weber S; Niessen MT; Prox J; Lüllmann-Rauch R; Schmitz A; Schwanbeck R; Blobel CP; Jorissen E; de Strooper B; Niessen CM; Saftig P
    Development; 2011 Feb; 138(3):495-505. PubMed ID: 21205794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin.
    Liu B; Willette-Brown J; Liu S; Chen X; Fischer SM; Hu Y
    Cell Death Differ; 2011 Dec; 18(12):1854-64. PubMed ID: 21566664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
    Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R
    Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability?
    Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation.
    Abu-Humaidan AH; Ananthoju N; Mohanty T; Sonesson A; Alberius P; Schmidtchen A; Garred P; Sørensen OE
    J Immunol; 2014 Apr; 192(7):3355-64. PubMed ID: 24591374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation.
    Kalailingam P; Tan HB; Jain N; Sng MK; Chan JSK; Tan NS; Thanabalu T
    Sci Rep; 2017 Aug; 7(1):7311. PubMed ID: 28779153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.
    Denning MF; Dlugosz AA; Threadgill DW; Magnuson T; Yuspa SH
    J Biol Chem; 1996 Mar; 271(10):5325-31. PubMed ID: 8621384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells.
    Hartl D; He CH; Koller B; Da Silva CA; Homer R; Lee CG; Elias JA
    J Biol Chem; 2008 Nov; 283(48):33472-82. PubMed ID: 18824549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.
    Mendelson K; Swendeman S; Saftig P; Blobel CP
    J Biol Chem; 2010 Aug; 285(32):25024-32. PubMed ID: 20529858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation.
    Sevilla LM; Latorre V; Sanchis A; Pérez P
    J Invest Dermatol; 2013 Feb; 133(2):361-70. PubMed ID: 22951731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal ADAM17 is dispensable for notch activation.
    Groot AJ; Cobzaru C; Weber S; Saftig P; Blobel CP; Kopan R; Vooijs M; Franzke CW
    J Invest Dermatol; 2013 Sep; 133(9):2286-8. PubMed ID: 23657465
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function.
    Peng G; Tsukamoto S; Umehara Y; Kishi R; Tominaga M; Takamori K; Okumura K; Ogawa H; Ikeda S; Niyonsaba F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
    Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ
    Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model.
    Sato K; Takaishi M; Tokuoka S; Sano S
    PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.